{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:35Z","timestamp":1792682795436,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":685,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0283"],"award-info":[{"award-number":["W81XWH-15-1-0283"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0284"],"award-info":[{"award-number":["W81XWH-15-1-0284"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AQ-1980-20190330"],"award-info":[{"award-number":["AQ-1980-20190330"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13311-021-01113-7","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T07:46:32Z","timestamp":1633419992000},"page":"2707-2721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury"],"prefix":"10.1016","volume":"18","author":[{"given":"Eda","family":"Bozdemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio A.","family":"Vigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Bugay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiola","family":"Stoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceyda","family":"Tunca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Cavazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore E.","family":"Liston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9000-0722","authenticated-orcid":false,"given":"James D.","family":"Lechleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01113-7_bib1","unstructured":"CDC. TBI: Get the Facts | Concussion | Traumatic Brain Injury | CDC Injury Center. 2019; https:\/\/www.cdc.gov\/traumaticbraininjury\/get_the_facts.html."},{"issue":"5","key":"10.1007\/s13311-021-01113-7_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/neu.2018.5734","article-title":"White Matter Correlates of Mild Traumatic Brain Injuries in Women Subjected to Intimate-Partner Violence: A Preliminary Study","volume":"36","author":"Valera","year":"2019","journal-title":"J Neurotrauma."},{"key":"10.1007\/s13311-021-01113-7_bib3","series-title":"Invisible wounds of war: psychological and cognitive injuries, their consequences, and services to assist recovery","author":"Tanielian","year":"2008"},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/HTR.0000000000000156","article-title":"Trends in Sports- and Recreation-Related Traumatic Brain Injuries Treated in US Emergency Departments: The National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP) 2001\u20132012","volume":"30","author":"Coronado","year":"2015","journal-title":"J Head Trauma Rehabil."},{"key":"10.1007\/s13311-021-01113-7_bib5","unstructured":"CDC, NIH, DoD, Panel VL. Report to Congress on Traumatic Brain Injury in the United States: Understanding the Public Health Problem among Current and Former Military Personnel. 2013."},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","article-title":"Inflammation and neuroprotection in traumatic brain injury","volume":"72","author":"Corps","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/neu.2018.6333","article-title":"A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal Excitability","volume":"37","author":"Bugay","year":"2020","journal-title":"J Neurotrauma."},{"issue":"9","key":"10.1007\/s13311-021-01113-7_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40263-016-0355-2","article-title":"Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature","volume":"30","author":"Gruenbaum","year":"2016","journal-title":"CNS Drugs."},{"issue":"43","key":"10.1007\/s13311-021-01113-7_bib9","doi-asserted-by":"crossref","first-page":"71052","DOI":"10.18632\/oncotarget.11958","article-title":"Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nurt.2009.10.016","article-title":"Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury","volume":"7","author":"Ziebell","year":"2010","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-021-01113-7_bib11","doi-asserted-by":"crossref","unstructured":"Sizemore G, Lucke-Wold B, Rosen C, Simpkins JW, Bhatia S, Sun D. Temporal Lobe Epilepsy, Stroke, and Traumatic Brain Injury: Mechanisms of Hyperpolarized, Depolarized, and Flow-Through Ion Channels Utilized as Tri-Coordinate Biomarkers of Electrophysiologic Dysfunction. OBM Neurobiol. 2018;2(2).","DOI":"10.21926\/obm.neurobiol.1802009"},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MAJ.0000000000000506","article-title":"Traumatic brain injury and mitochondrial dysfunction","volume":"350","author":"Hiebert","year":"2015","journal-title":"Am J Med Sci."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R115.053744","article-title":"Glial Contributions to Neural Function and Disease","volume":"15","author":"Rasband","year":"2016","journal-title":"Mol Cell Proteomics."},{"issue":"12","key":"10.1007\/s13311-021-01113-7_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","article-title":"Molecular dissection of reactive astrogliosis and glial scar formation","volume":"32","author":"Sofroniew","year":"2009","journal-title":"Trends Neurosci."},{"issue":"Pt 3","key":"10.1007\/s13311-021-01113-7_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","article-title":"Astrocyte roles in traumatic brain injury","volume":"275","author":"Burda","year":"2016","journal-title":"Exp Neurol."},{"key":"10.1007\/s13311-021-01113-7_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial Activation in Traumatic Brain Injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front Aging Neurosci."},{"issue":"9","key":"10.1007\/s13311-021-01113-7_bib17","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V88.9.3569.bloodjournal8893569","article-title":"Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium","volume":"88","author":"Kohno","year":"1996","journal-title":"Blood."},{"issue":"4","key":"10.1007\/s13311-021-01113-7_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/jcbfm.2012.214","article-title":"P2Y1R-initiated, IP3R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse","volume":"33","author":"Zheng","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/neu.2012.2488","article-title":"Purinergic 2Y(1) receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model","volume":"30","author":"Talley Watts","year":"2013","journal-title":"J Neurotrauma."},{"key":"10.1007\/s13311-021-01113-7_bib20","doi-asserted-by":"crossref","unstructured":"Zheng W, Watts LT, Holstein DM, Prajapati SI, Keller C, Grass EH, et al. Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One. 2010;5(12):e14401.","DOI":"10.1371\/journal.pone.0014401"},{"issue":"35","key":"10.1007\/s13311-021-01113-7_bib21","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1002\/anie.201605147","article-title":"The Molecular Mechanism of P2Y1 Receptor Activation","volume":"55","author":"Yuan","year":"2016","journal-title":"Angew Chem Int Ed Engl."},{"issue":"8","key":"10.1007\/s13311-021-01113-7_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.bjp.0704254","article-title":"Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells","volume":"134","author":"Gessi","year":"2001","journal-title":"Br J Pharmacol."},{"key":"10.1007\/s13311-021-01113-7_bib24","doi-asserted-by":"crossref","unstructured":"Liston TE, Hinz S, Muller C, Holstein D, Wendling J, Melton RJ, et al. Nucleotide P2Y1 Receptor Agonists are In Vitro and In Vivo Prodrugs of A1\/A3 Adenosine Receptor Agonists: Implications for Roles of P2Y1 and A1\/A3 Adenosine Receptors in Health and Disease. Purinergic Signal. 2020;in press.","DOI":"10.1007\/s11302-020-09732-z"},{"issue":"10","key":"10.1007\/s13311-021-01113-7_bib25","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1021\/jm010538v","article-title":"Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists","volume":"45","author":"Ravi","year":"2002","journal-title":"J Med Chem."},{"key":"10.1007\/s13311-021-01113-7_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-3816-2_11","article-title":"The Controlled Cortical Impact Model of Experimental Brain Trauma: Overview, Research Applications, and Protocol","volume":"1462","author":"Osier","year":"2016","journal-title":"Methods Mol Biol."},{"issue":"19","key":"10.1007\/s13311-021-01113-7_bib27","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1523\/JNEUROSCI.3579-16.2017","article-title":"Synaptic Targeting of Double-Projecting Ventral CA1 Hippocampal Neurons to the Medial Prefrontal Cortex and Basal Amygdala","volume":"37","author":"Kim","year":"2017","journal-title":"J Neurosci."},{"issue":"6","key":"10.1007\/s13311-021-01113-7_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn3945","article-title":"Neuronal circuits for fear and anxiety","volume":"16","author":"Tovote","year":"2015","journal-title":"Nat Rev Neurosci."},{"key":"10.1007\/s13311-021-01113-7_bib29","doi-asserted-by":"crossref","unstructured":"Xu C, Krabbe S, Grundemann J, Botta P, Fadok JP, Osakada F, et al. Distinct Hippocampal Pathways Mediate Dissociable Roles of Context in Memory Retrieval. Cell. 2016;167(4):961\u201372 e16.","DOI":"10.1016\/j.cell.2016.09.051"},{"issue":"4","key":"10.1007\/s13311-021-01113-7_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nmeth.2839","article-title":"A synthetic luciferin improves bioluminescence imaging in live mice","volume":"11","author":"Evans","year":"2014","journal-title":"Nature methods."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11064-016-1848-6","article-title":"Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology","volume":"42","author":"Parpura","year":"2017","journal-title":"Neurochem Res."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/cc2950","article-title":"Bench-to-bedside review: Apoptosis\/programmed cell death triggered by traumatic brain injury","volume":"9","author":"Zhang","year":"2005","journal-title":"Crit Care."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.05.102","article-title":"Spatiotemporal evolution of apoptotic neurodegeneration following traumatic injury to the developing rat brain","volume":"1107","author":"Bayly","year":"2006","journal-title":"Brain Res."},{"issue":"4","key":"10.1007\/s13311-021-01113-7_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","article-title":"Blood-brain barrier pathophysiology in traumatic brain injury","volume":"2","author":"Chodobski","year":"2011","journal-title":"Transl Stroke Res."},{"issue":"6","key":"10.1007\/s13311-021-01113-7_bib35","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1177\/0271678X19857818","article-title":"Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, \u201cM-type\u201d ) K(+) currents in neurons","volume":"40","author":"Vigil","year":"2020","journal-title":"J Cereb Blood Flow Metab."},{"issue":"4\u20136","key":"10.1007\/s13311-021-01113-7_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jphysparis.2014.08.006","article-title":"Memory labilization in reconsolidation and extinction\u2013evidence for a common plasticity system?","volume":"108","author":"Almeida-Correa","year":"2014","journal-title":"J Physiol Paris."},{"issue":"9","key":"10.1007\/s13311-021-01113-7_bib37","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1089\/neu.2009.0953","article-title":"The multivariate concentric square field test reveals behavioral profiles of risk taking, exploration, and cognitive impairment in mice subjected to traumatic brain injury","volume":"27","author":"Ekmark-Lewen","year":"2010","journal-title":"J Neurotrauma."},{"issue":"19","key":"10.1007\/s13311-021-01113-7_bib38","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/neu.2013.3320","article-title":"Acute reduction of microglia does not alter axonal injury in a mouse model of repetitive concussive traumatic brain injury","volume":"31","author":"Bennett","year":"2014","journal-title":"J Neurotrauma."},{"issue":"5","key":"10.1007\/s13311-021-01113-7_bib39","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/npp.2013.338","article-title":"Dopamine D1 receptor activation rescues extinction impairments in low-estrogen female rats and induces cortical layer-specific activation changes in prefrontal-amygdala circuits","volume":"39","author":"Rey","year":"2014","journal-title":"Neuropsychopharmacology."},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuroscience.2009.09.011","article-title":"Estrous cycle phase and gonadal hormones influence conditioned fear extinction","volume":"164","author":"Milad","year":"2009","journal-title":"Neuroscience."},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/npp.2015.202","article-title":"Estradiol and Progesterone have Opposing Roles in the Regulation of Fear Extinction in Female Rats","volume":"41","author":"Graham","year":"2016","journal-title":"Neuropsychopharmacology."},{"issue":"6","key":"10.1007\/s13311-021-01113-7_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1570159X14666160309123554","article-title":"Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury","volume":"14","author":"Brotfain","year":"2016","journal-title":"Curr Neuropharmacol."},{"key":"10.1007\/s13311-021-01113-7_bib43","doi-asserted-by":"crossref","unstructured":"Matsumoto YK, Kasai M, Tomihara K. The enhancement effect of estradiol on contextual fear conditioning in female mice. PLoS One. 2018;13(5):e0197441.","DOI":"10.1371\/journal.pone.0197441"},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11940-002-0004-6","article-title":"Cognitive Impairment Following Traumatic Brain Injury","volume":"4","author":"Arciniegas","year":"2002","journal-title":"Curr Treat Options Neurol."},{"issue":"6","key":"10.1007\/s13311-021-01113-7_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/HTR.0000000000000289","article-title":"Childhood Traumatic Brain Injury and the Associations With Risk Behavior in Adolescence and Young Adulthood: A Systematic Review","volume":"32","author":"Kennedy","year":"2017","journal-title":"J Head Trauma Rehabil."},{"issue":"4","key":"10.1007\/s13311-021-01113-7_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7205\/MILMED-D-13-00241","article-title":"Risk-taking behaviors and impulsivity among veterans with and without PTSD and mild TBI","volume":"179","author":"James","year":"2014","journal-title":"Mil Med."},{"key":"10.1007\/s13311-021-01113-7_bib47","doi-asserted-by":"crossref","unstructured":"Ozga-Hess JE, Whirtley C, O'Hearn C, Pechacek K, Vonder Haar C. Unilateral parietal brain injury increases risk-taking on a rat gambling task. Exp Neurol. 2020;327:113217.","DOI":"10.1016\/j.expneurol.2020.113217"},{"key":"10.1007\/s13311-021-01113-7_bib48","doi-asserted-by":"crossref","unstructured":"Rudolphi KA, Schubert P. Adenosine and brain ischemia. In: Belardinell L, Pelleg A, editors. Adenosine and ademime nucleotides: from molecular biology to integrative physiology: Kluwer Norwell; 1995. p. 391\u20136.","DOI":"10.1007\/978-1-4615-2011-5_43"},{"key":"10.1007\/s13311-021-01113-7_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(94)90523-1","article-title":"Adenosine A3 receptor stimulation and cerebral ischemia","volume":"263","author":"von Lubitz","year":"1994","journal-title":"Eur J Pharmacol."},{"issue":"2\u20133","key":"10.1007\/s13311-021-01113-7_bib50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(98)00977-7","article-title":"Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: neuronal and glial effects","volume":"367","author":"von Lubitz","year":"1999","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"10.1007\/s13311-021-01113-7_bib51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/13543784.10.4.619","article-title":"Adenosine in the treatment of stroke: yes, maybe, or absolutely not?","volume":"10","author":"von Lubitz","year":"2001","journal-title":"Expert Opin Investig Drugs."},{"issue":"4","key":"10.1007\/s13311-021-01113-7_bib52","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.ajpath.2011.07.006","article-title":"A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats","volume":"179","author":"Choi","year":"2011","journal-title":"Am J Pathol."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12974-020-02009-7","article-title":"Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury","volume":"17","author":"Farr","year":"2020","journal-title":"J Neuroinflammation."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11302-007-9086-7","article-title":"Internalization and desensitization of adenosine receptors","volume":"4","author":"Klaasse","year":"2008","journal-title":"Purinergic Signal."},{"key":"10.1007\/s13311-021-01113-7_bib55","doi-asserted-by":"crossref","unstructured":"Trincavelli ML, Ciampi O, Martini C. The Desensitization as A3 Adenosine Receptor Regulation: Physiopathological Implications. In: Borea PA, editor. A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics. p. 75\u201390.","DOI":"10.1007\/978-90-481-3144-0_5"},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib56","first-page":"26","article-title":"Adenosine in the control of the cerebral circulation","volume":"1","author":"Phillis","year":"1989","journal-title":"Cerebrovasc Brain Metab Rev."},{"issue":"1","key":"10.1007\/s13311-021-01113-7_bib57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1748-1716.1991.tb09133.x","article-title":"Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism","volume":"142","author":"Ballarin","year":"1991","journal-title":"Acta Physiol Scand."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728214.8.2.537","article-title":"Adenosine receptor agonists: from basic medicinal chemistry to clinical development","volume":"8","author":"Yan","year":"2003","journal-title":"Expert Opin Emerg Drugs."},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/neu.1998.15.163","article-title":"Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat","volume":"15","author":"Bell","year":"1998","journal-title":"J Neurotrauma."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00003246-200102000-00033","article-title":"Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury","volume":"29","author":"Bell","year":"2001","journal-title":"Crit Care Med."},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1023\/A:1023601007518","article-title":"Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration","volume":"23","author":"Fedorova","year":"2003","journal-title":"Cell Mol Neurobiol."},{"issue":"8","key":"10.1007\/s13311-021-01113-7_bib62","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/jnr.21071","article-title":"Activation of adenosine A3 receptors reduces ischemic brain injury in rodents","volume":"84","author":"Chen","year":"2006","journal-title":"J Neurosci Res."},{"key":"10.1007\/s13311-021-01113-7_bib63","unstructured":"Zheng W, Talley Watts L, Sayre NL, Holstein D, Lechleiter JD. Targeting Astrocyte Mitochondrial ATP production as a Strategy to Treat Brain Injuries. In: Sontheimer H, editor. Glial Biology in Medicine; Birmingham, AB2012."},{"issue":"12","key":"10.1007\/s13311-021-01113-7_bib64","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.RES.0000172556.05576.4c","article-title":"Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice","volume":"96","author":"Li","year":"2005","journal-title":"Circ Res."},{"issue":"19","key":"10.1007\/s13311-021-01113-7_bib65","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1523\/JNEUROSCI.5572-07.2008","article-title":"Loss of IP3 receptor-dependent Ca2+ increases in hippocampal astrocytes does not affect baseline CA1 pyramidal neuron synaptic activity","volume":"28","author":"Petravicz","year":"2008","journal-title":"J Neurosci."},{"issue":"6","key":"10.1007\/s13311-021-01113-7_bib66","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/j.pain.0000000000001177","article-title":"Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms","volume":"159","author":"Wahlman","year":"2018","journal-title":"Pain."},{"issue":"23","key":"10.1007\/s13311-021-01113-7_bib67","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1021\/jm501021n","article-title":"In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists","volume":"57","author":"Tosh","year":"2014","journal-title":"J Med Chem."},{"issue":"7","key":"10.1007\/s13311-021-01113-7_bib68","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/j.pain.0000000000001857","article-title":"Treatment of chronic neuropathic pain: purine receptor modulation","volume":"161","author":"Jacobson","year":"2020","journal-title":"Pain."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cellimm.2009.03.020","article-title":"The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease","volume":"258","author":"Ochaion","year":"2009","journal-title":"Cell Immunol."},{"issue":"11","key":"10.1007\/s13311-021-01113-7_bib70","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn1785","article-title":"Pathways modulating neural KCNQ\/M (Kv7) potassium channels","volume":"6","author":"Delmas","year":"2005","journal-title":"Nat Rev Neurosci."},{"key":"10.1007\/s13311-021-01113-7_bib71","unstructured":"Gamper N, Shapiro M. KCNQ Channels. In: Zheng J, Trudeau M, editors. Handbook of Ion Channels. Boca Raton: CRC Press; 2015."},{"issue":"3","key":"10.1007\/s13311-021-01113-7_bib72","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/mol.58.3.591","article-title":"Retigabine, a novel anti-convulsant, enhances activation of KCNQ2\/Q3 potassium channels","volume":"58","author":"Wickenden","year":"2000","journal-title":"Mol Pharmacol."},{"issue":"2\u20133","key":"10.1007\/s13311-021-01113-7_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(97)01249-1","article-title":"The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells","volume":"336","author":"Rundfeldt","year":"1997","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2006.03.024","article-title":"Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures","volume":"51","author":"Boscia","year":"2006","journal-title":"Neuropharmacology."},{"issue":"2","key":"10.1007\/s13311-021-01113-7_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/phar.1185","article-title":"Ezogabine: a novel antiepileptic for adjunctive treatment of partial-onset seizures","volume":"33","author":"Amabile","year":"2013","journal-title":"Pharmacotherapy."},{"key":"10.1007\/s13311-021-01113-7_bib76","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","article-title":"G proteins: transducers of receptor-generated signals","volume":"56","author":"Gilman","year":"1987","journal-title":"Annu Rev Biochem."},{"issue":"6","key":"10.1007\/s13311-021-01113-7_bib77","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0026-895X(25)10571-3","article-title":"G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain","volume":"48","author":"Abbracchio","year":"1995","journal-title":"Mol Pharmacol."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01113-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:51:28Z","timestamp":1761807088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923007341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1878747923007341"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01113-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-145867\/v1","asserted-by":"object"}]},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01113-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}